Case Study: Leading Biotechnology Company achieves compliant, end-to-end labeling visibility with Appian

How Appian can help transform the drug labeling process

A leading biotechnology company with more than 20,000 employees in 100+ countries faced a fragmented, highly manual labeling process that lacked real-time end-to-end visibility, consistent communication across jurisdictions, and traceability for regulatory audits—resulting in branding inconsistencies, inefficient access to critical data, and excessive costs.

The company implemented Appian’s low-code platform to automate workflows, improve process monitoring and quality controls, and integrate labeling with product registrations, regulatory documents, safety signaling, supply chain and corporate data. This digital transformation standardized and updated approved documentation, streamlined global product creation, and delivered end-to-end visibility and auditability of the entire labeling process.